These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10723769)

  • 61. [Tabletting of a nitroglyceryl inclusion compound and testing of sustained release tablets].
    Kata M; Wayer M; Szabóné Révész P; Kedvessy G; Stadler-Szöke A; Szejtli J
    Acta Pharm Hung; 1986 Jul; 56(4):157-63. PubMed ID: 3092569
    [No Abstract]   [Full Text] [Related]  

  • 62. [Study on tablets. XVIII. Preparation of basic granulates for tablets by pulverization].
    Malý J; Rak J
    Cesk Farm; 1968 Mar; 17(3):122-6. PubMed ID: 5666302
    [No Abstract]   [Full Text] [Related]  

  • 63. Spectrofluorometric determination of ibuprofen in pharmaceutical formulations.
    Damiani PC; Bearzotti M; Cabezón MA
    J Pharm Biomed Anal; 2001 Jun; 25(3-4):679-83. PubMed ID: 11377049
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of hybrid materials by means of inverse gas chromatography and chemometrics.
    Kołodziejek J; Voelkel A; Heberger K
    J Pharm Sci; 2013 May; 102(5):1524-31. PubMed ID: 23460032
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predictive Performance Comparison of Computed Linear and Quadratic Multivariate Models for In-Situ UV Fiber Optics Tablet Dissolution Testing.
    Sardhara R; Chaturvedi K; Shah HS; Vinjamuri BP; Al-Achi A; Morris KR; Haware RV
    Eur J Pharm Sci; 2021 Jun; 161():105806. PubMed ID: 33722733
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Effects of some technological factors on the release of sulfadimidine from granulates (author's transl)].
    Jheljazkova J; Isaew I; Iwanowa J
    Pharmazie; 1980; 35(9):553-4. PubMed ID: 7433508
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A pharmacokinetic comparison of ibuprofen sustained-release tablets given to young and elderly patients.
    Kendall MJ; Jubb R; Bird HA; le Gallez P; Hill J; Taggart AJ; Rau R
    J Clin Pharm Ther; 1990 Feb; 15(1):35-40. PubMed ID: 2318915
    [No Abstract]   [Full Text] [Related]  

  • 68. Granulates, of low content in active substances, prepared using a fluid bed process.
    Motto D
    Boll Chim Farm; 1977 May; 116(5):307-13. PubMed ID: 889634
    [No Abstract]   [Full Text] [Related]  

  • 69. Contribution to the methodology of optimization and in-process control of some physical properties of pharmaceutical bulk substances and granulates.
    Dávid A; Nagy P; Pogány J; Rácz I; Takács G
    J Pharm Biomed Anal; 1983; 1(4):459-67. PubMed ID: 16867784
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [New formulations to be used in dental pharmacology].
    Korbar-Smid J; Sumer-Toldi D
    Zobozdrav Vestn; 1980; 35(5-6):179-83. PubMed ID: 6943878
    [No Abstract]   [Full Text] [Related]  

  • 71. Sorbitol in bulk compounding formulations.
    Am J Hosp Pharm; 1967 Jul; 24(7):378. PubMed ID: 6043708
    [No Abstract]   [Full Text] [Related]  

  • 72. Clinical Evaluation of a Sustained Release Antihistamine, Avil Retard.
    Gupta BN; Gupta RN
    Indian J Dermatol Venereol; 1971; 37(6):203-208. PubMed ID: 29154348
    [No Abstract]   [Full Text] [Related]  

  • 73. ["Non-solvent shock agglomeration technology" as a new alternative method for work on ibuprofen. 4. Production and evaluation of quick release forms].
    Möller T; Korsatko W
    Pharmazie; 2000 Jan; 55(1):53-8. PubMed ID: 10683872
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ["Non-solvent shock agglomeration"--the technology of a new alternative method for determination of ibuprofen. 6. Stability of s(+)-ibuprofen].
    Möller T; Korsatko W
    Pharmazie; 2000 Jun; 55(6):449-53. PubMed ID: 10907254
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG; Chi MH; Kim YI; Woo JS; Park ES
    Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rationale for ibuprofen co-administration with antacids: potential interaction mechanisms affecting drug absorption.
    Parojcić J; Corrigan OI
    Eur J Pharm Biopharm; 2008 Jun; 69(2):640-7. PubMed ID: 18280125
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Anciliary substances in production of tablets].
    Gandel' VG
    Aptechn Delo; 1966; 15(3):71-4. PubMed ID: 4868988
    [No Abstract]   [Full Text] [Related]  

  • 78. ["Non-solvent shock agglomeration"--technology of a new alternative method for sustained release of ibuprofen. 5. Production and evaluation of retard formulations].
    Möller T; Korsatko W
    Pharmazie; 2000 Feb; 55(2):114-9. PubMed ID: 10723769
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.